Elucid PlaqueIQ | findAIList | Find AI List

Home/Tools/Personal

Elucid PlaqueIQ

4.6

Free

Users praise PlaqueIQ for its accurate plaque quantification, detailed visualization, and ease of integration into clinical workflows, leading to improved diagnostic confidence and treatment planning.

The only FDA-cleared, non-invasive CTA plaque assessment that’s powered by ground-truth histology, providing physicians with comprehensive patient, vessel, and lesion-level plaque composition and quantification data.

PersonalFree pricingUpdated 2026-03-17

Best fits

Plaque QuantificationPlaque Characterization

0 views

0 saves

Elucid PlaqueIQ interface

About Elucid PlaqueIQ

Elucid PlaqueIQ is an AI-powered medical imaging software that provides quantitative analysis of coronary and carotid plaque composition using CT angiography (CTA). It leverages CT Virtual Histology™, trained and validated on ground-truth histopathology, the gold standard for plaque characterization. The software quantifies and classifies plaque morphology, identifying lipid-rich necrotic core, calcified, and non-calcified components. PlaqueIQ delivers an actionable report with 3D visualization of vessel structure, critical arterial volumes, and plaque quantification, enabling patient-specific treatment pathways. It integrates into existing clinical workflows via DICOM-wrapped PDFs delivered to PACS and an interactive browser for detailed coronary tree interrogation. The underlying algorithms demonstrate excellent correlation and accuracy for tissue characterization when compared to ex vivo histopathology, providing physicians with comprehensive patient, vessel, and lesion-level plaque composition and quantification data. Elucid FFRCT, currently under development, will leverage histology-based plaque composition to calculate lesion-level FFRCT measurements.

Core Capabilities

Elucid PlaqueIQ is an AI-powered medical imaging software that provides quantitative analysis of coronary and carotid plaque composition using CT angiography (CTA).

Main Tasks

Use Cases

Patient with suspected coronary artery disease undergoing CTA

Determining the severity and composition of coronary artery plaques to guide treatment decisions.

VIEW EXECUTION STEPS

1.

1. Acquire CTA images of the patient's coronary arteries.

2.

2. Upload the DICOM images to Elucid PlaqueIQ.

3.

3. The software automatically segments and quantifies plaque volume and composition.

4.

4. Review the 3D visualization and quantitative report to assess the extent of calcified, non-calcified, and lipid-rich plaques.

5.

5. Determine the appropriate treatment strategy based on the plaque characteristics, such as medical therapy, PCI, or CABG.

Patient with carotid stenosis undergoing CTA

Assessing the risk of stroke based on the composition of carotid artery plaques.

VIEW EXECUTION STEPS

1.

1. Acquire CTA images of the patient's carotid arteries.

2.

2. Upload the DICOM images to Elucid PlaqueIQ.

3.

3. The software analyzes the plaque morphology and identifies high-risk features, such as lipid-rich necrotic core.

4.

4. Review the report to assess the risk of plaque rupture and ischemic stroke.

5.

5. Determine the appropriate treatment strategy based on the plaque characteristics, such as medical therapy or carotid endarterectomy.

Research study investigating the impact of plaque composition on cardiovascular events

Quantifying plaque characteristics in a large cohort of patients to identify predictors of future events.

VIEW EXECUTION STEPS

1.

1. Acquire CTA images from study participants.

2.

2. Upload the DICOM images to Elucid PlaqueIQ.

3.

3. The software automatically quantifies plaque volume and composition for each patient.

4.

4. Correlate plaque characteristics with clinical outcomes to identify predictors of cardiovascular events.

5.

5. Publish the findings in a peer-reviewed journal.

Physician using PlaqueIQ to support clinical decisions such as intervention versus drug-therapy

Better understand patient risk to tailor medical guidance and prevent heart attack and stroke

VIEW EXECUTION STEPS

1.

1. Visualize the plaque type and amount in a patient’s vessels.

2.

2. Assess stable plaque versus more high-risk plaque.

3.

3. Determine the most appropriate therapy based on the patient’s unique plaque composition.

Tailoring treatment to patient-specific vasculature

Utilizing actionable, risk-based, lesion-specific plaque composition

VIEW EXECUTION STEPS

1.

1. PlaqueIQ generates detailed lesion-specific analysis.

2.

2. Risk factors are determined based on plaque composition.

3.

3. A tailored treatment plan is developed based on those risk factors.

Evaluate the effectiveness of a new drug on plaque regression.

Objectively measure changes in plaque volume and composition over time.

VIEW EXECUTION STEPS

1.

1. Acquire CTA images before and after drug treatment.

2.

2. Upload the DICOM images to Elucid PlaqueIQ.

3.

3. The software quantifies plaque volume and composition at both time points.

4.

4. Compare the pre- and post-treatment plaque characteristics to assess drug efficacy.

5.

5. Present the findings at a scientific conference.